Zobrazeno 1 - 10
of 1 898
pro vyhledávání: '"Sreeram V"'
Autor:
Robert Lowe, Marita G. Overhoff, Sreeram V. Ramagopalan, James C. Garbe, James Koh, Martha R. Stampfer, David H. Beach, Vardhman K. Rakyan, Cleo L. Bishop
Publikováno v:
Genome Biology, Vol 25, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/4e4acf8addd04514a72a64689dc3c3cb
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 11 (2024)
In this latest update, we explore the recent announcement by Canada’s Drug Agency (CDA-AMC, formerly CADTH) on their pilot to include the societal perspective in the evaluation of certain new medicines; a recent Office of Health Economics (OHE) r
Externí odkaz:
https://doaj.org/article/6252f13a678047849743b433c45bf759
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 10 (2024)
Externí odkaz:
https://doaj.org/article/0e443eabfc8c467aa15cfb0a3f5ac51b
Autor:
Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, Bill Malcolm, Jose Diaz, Grace Mitchell, Jonathan Pearson-Stuttard, Louis P Garrison Jr
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/f24885864e734f09994c94a4839754e2
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 9 (2024)
Externí odkaz:
https://doaj.org/article/ac535fd87a54473fab495d3a02b33586
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 8 (2024)
In this update, we discuss recent US FDA guidance offering more specific guidelines on appropriate study design and analysis to support causal inference for non-interventional studies and the launch of the European Medicines Agency (EMA) and the Head
Externí odkaz:
https://doaj.org/article/befa342d72734a648f96da9e4e300dce
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 7 (2024)
Externí odkaz:
https://doaj.org/article/1623ca576d264796a4957219e2fcc879
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Contemporary debates about drug pricing feature several widely held misconceptions, including the relationship between incentives and innovation, the proportion of total healthcare spending on pharmaceuticals, and whether the econ
Externí odkaz:
https://doaj.org/article/d89ed61b4c4a4740b7bc72e53f3f236e
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/5f14e94285f84df4a7380f20621ea5fb
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 6, Iss 13 (2024)
In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Far
Externí odkaz:
https://doaj.org/article/d3c9f59e8747475a96b2efec8b3342b7